› 4wpf

X-ray diffraction
2.2Å resolution

Crystal structure of RORc in complex with a phenyl sulfonamide agonist

Released:
DOI: 10.2210/pdb4wpf/pdb
PDB 4wpf coloured by chain and viewed from the front.
PDB 4wpf coloured by chain and viewed from the side.
PDB 4wpf coloured by chain and viewed from the top.
Source organism: Homo sapiens
Primary publication:
Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action.
René O, Fauber BP, Boenig Gde L, Burton B, Eidenschenk C, Everett C, Gobbi A, Hymowitz SG, Johnson AR, Kiefer JR, Liimatta M, Lockey P, Norman M, Ouyang W, Wallweber HA, Wong H
ACS Med Chem Lett 6 276-81 (2015)
PMID: 25815138

Function and Biology Details

Biochemical function:
  • not assigned
Biological process:
  • not assigned
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assembly composition:
hetero dimer (preferred)
Entry contents:
2 distinct polypeptide molecules
Macromolecules (2 distinct):
Nuclear receptor ROR-gamma Chains: A, D
Molecule details ›
Chains: A, D
Length: 264 amino acids
Theoretical weight: 30.83 KDa
Source organism: Homo sapiens
Expression system: Escherichia coli
UniProt:
  • Canonical: P51449 (Residues: 262-509; Coverage: 48%)
Gene names: NR1F3, RORC, RORG, RZRG
Sequence domains: Ligand-binding domain of nuclear hormone receptor
Structure domains: Retinoid X Receptor
RHKILHRLLQEGSPS Chains: B, E
Molecule details ›
Chains: B, E
Length: 11 amino acids
Theoretical weight: 1.36 KDa
Source organism: Homo sapiens
Expression system: Not provided

Ligands and Environments

1 bound ligand:
Ligand 3SN 2 x 3SN
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: ALS BEAMLINE 5.0.2
Spacegroup: P41
Unit cell:
a: 61.692Å b: 61.692Å c: 155.232Å
α: 90° β: 90° γ: 90°
R-values:
R R work R free
0.18 0.175 0.227
Expression systems:
  • Escherichia coli
  • Not provided

Quick links

Citations

3 review citations

(Inverse) Agonists of Retinoic Acid-Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease.
Jetten et al. (2020)
2 more

8 mentions without citation

Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols.
Slominski et al. (2017)
7 more